{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T09:21:24Z","timestamp":1791019284045,"version":"4.1.0"},"reference-count":145,"publisher":"Elsevier BV","issue":"2","content-domain":{"domain":["cancerletters.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.canlet.2012.11.052","type":"journal-article","created":{"date-parts":[[2012,12,6]],"date-time":"2012-12-06T06:00:51Z","timestamp":1354773651000},"page":"141-149","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["STAT3 as a therapeutic target for Epstein-Barr virus (EBV) \u2013 associated nasopharyngeal carcinoma"],"prefix":"10.1016","volume":"330","author":[{"given":"Yeung","family":"Ho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai-Wah","family":"Tsao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Musheng","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian Wai Yan","family":"Lui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2012.11.052_b0005","series-title":"Cancer Epidemiology and Prevention","author":"Anderson","year":"2006"},{"key":"10.1016\/j.canlet.2012.11.052_b0010","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1093\/annonc\/mdf179","article-title":"Nasopharyngeal carcinoma","volume":"13","author":"Chan","year":"2002","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.canlet.2012.11.052_b0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399407000312","article-title":"Nasopharyngeal carcinoma: molecular pathogenesis and therapeutic developments","volume":"9","author":"Tao","year":"2007","journal-title":"Expert Rev. Mol. Med."},{"issue":"2005","key":"10.1016\/j.canlet.2012.11.052_b0020","first-page":"243","article-title":"Estimates of cancer incidence in China for 2000 and projections for 2005","volume":"14","author":"Yang","year":"2000","journal-title":"Cancer Epidemiol. Biomar. Prev."},{"key":"10.1016\/j.canlet.2012.11.052_b0025","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S1535-6108(04)00119-9","article-title":"Focus on nasopharyngeal carcinoma","volume":"5","author":"Lo","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2012.11.052_b0030","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S1044579X02000858","article-title":"Epidemiology of nasopharyngeal carcinoma","volume":"12","author":"Yu","year":"2002","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.canlet.2012.11.052_b0035","unstructured":"K. C. Altekruse SF, M. Krapcho, N. Neyman, R. Aminou, W. Waldron, J. Ruhl, N. Howlader, Z. Tatalovich, H. Cho, A. Mariotto, et al., SEER Cancer Statistics, Review, 1975\u20132007, 2010."},{"key":"10.1016\/j.canlet.2012.11.052_b0040","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/annonc\/mdl320","article-title":"Epidemiology of nasopharyngeal carcinoma in the United States: improved survival of Chinese patients within the keratinizing squamous cell carcinoma histology","volume":"18","author":"Ou","year":"2007","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.canlet.2012.11.052_b0045","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1136\/jcp.45.5.396","article-title":"Epstein-Barr virus DNA in nasopharyngeal carcinomas from Chinese patients in Hong Kong","volume":"45","author":"Dickens","year":"1992","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.canlet.2012.11.052_b0050","doi-asserted-by":"crossref","first-page":"4737","DOI":"10.1073\/pnas.71.12.4737","article-title":"Direct evidence for the presence of Epstein-Barr virus DNA and nuclear antigen in malignant epithelial cells from patients with poorly differentiated carcinoma of the nasopharynx","volume":"71","author":"Klein","year":"1974","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.canlet.2012.11.052_b0055","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/(SICI)1096-9896(199710)183:2<164::AID-PATH919>3.0.CO;2-J","article-title":"The association of squamous cell carcinomas of the nasopharynx with Epstein-Barr virus shows geographical variation reminiscent of Burkitt\u2019s lymphoma","volume":"183","author":"Nicholls","year":"1997","journal-title":"J. Pathol."},{"key":"10.1016\/j.canlet.2012.11.052_b0060","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1016\/S0959-8049(03)00367-8","article-title":"Nasopharyngeal carcinomas: an update","volume":"39","author":"Spano","year":"2003","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.canlet.2012.11.052_b0065","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/ijc.2910530507","article-title":"Epstein-Barr virus carriage by nasopharyngeal carcinoma in situ","volume":"53","author":"Yeung","year":"1993","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2012.11.052_b0070","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/0046-8177(95)90195-7","article-title":"Epstein-Barr virus is detected in undifferentiated nasopharyngeal carcinoma but not in lymphoepithelioma-like carcinoma of the urinary bladder","volume":"26","author":"Gulley","year":"1995","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.canlet.2012.11.052_b0075","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1002\/cncr.0679","article-title":"Molecular pathology parameters in human nasopharyngeal carcinoma","volume":"94","author":"Shi","year":"2002","journal-title":"Cancer"},{"issue":"Suppl 7","key":"10.1016\/j.canlet.2012.11.052_b0730","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/annonc\/mdn466","article-title":"Optimizing approaches to head-and-neck cancers. Viruses in head-and-neck cancers: prevention and therapy","volume":"19","author":"Psyrri","year":"2008","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.canlet.2012.11.052_b0085","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s004280050402","article-title":"The Epstein-Barr virus: a group 1 carcinogen?","volume":"435","author":"Niedobitek","year":"1999","journal-title":"Virchows Arch."},{"key":"10.1016\/j.canlet.2012.11.052_b0090","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S1044579X0200086X","article-title":"Epstein-Barr virus in the pathogenesis of NPC","volume":"12","author":"Raab-Traub","year":"2002","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.canlet.2012.11.052_b0095","unstructured":"Proceedings of the IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Epstein-Barr Virus and Kaposi\u2019s Sarcoma Herpesvirus\/Human Herpesvirus 8. Lyon, France, 17\u201324 June 1997. 70, pp. 1\u2013492."},{"key":"10.1016\/j.canlet.2012.11.052_b0100","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1158\/1078-0432.CCR-0670-3","article-title":"Epstein-Barr virus and cancer","volume":"10","author":"Thompson","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2012.11.052_b0105","doi-asserted-by":"crossref","first-page":"5108","DOI":"10.1038\/sj.onc.1206556","article-title":"Epstein-Barr virus and oncogenesis: from latent genes to tumours","volume":"22","author":"Young","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2012.11.052_b0110","first-page":"25","article-title":"Human B-lymphoid cell lines","volume":"5","author":"Nilsson","year":"1992","journal-title":"Hum. Cell"},{"key":"10.1016\/j.canlet.2012.11.052_b0115","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.semcancer.2012.02.004","article-title":"The biology of EBV infection in human epithelial cells","volume":"22","author":"Tsao","year":"2012","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.canlet.2012.11.052_b0120","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199509143331103","article-title":"Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma","volume":"333","author":"Pathmanathan","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2012.11.052_b0125","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1593\/neo.05625","article-title":"Epstein-Barr virus infection alters cellular signal cascades in human nasopharyngeal epithelial cells","volume":"8","author":"Lo","year":"2006","journal-title":"Neoplasia"},{"key":"10.1016\/j.canlet.2012.11.052_b0130","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S1044579X02000901","article-title":"The significance of LMP1 expression in nasopharyngeal carcinoma","volume":"12","author":"Tsao","year":"2002","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.canlet.2012.11.052_b0135","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1002\/ijc.24567","article-title":"STAT3 activation contributes directly to Epstein-Barr virus-mediated invasiveness of nasopharyngeal cancer cells in vitro","volume":"125","author":"Lui","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2012.11.052_b0140","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1093\/carcin\/bgp253","article-title":"Cucurbitacin I elicits anoikis sensitization, inhibits cellular invasion and in vivo tumor formation ability of nasopharyngeal carcinoma cells","volume":"30","author":"Lui","year":"2009","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.canlet.2012.11.052_b0145","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0092-8674(00)81959-5","article-title":"Stat3 as an oncogene","volume":"98","author":"Bromberg","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2012.11.052_b0150","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S1074-7613(00)80011-4","article-title":"Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells","volume":"10","author":"Catlett-Falcone","year":"1999","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2012.11.052_b0155","doi-asserted-by":"crossref","first-page":"7001","DOI":"10.1038\/sj.onc.1205859","article-title":"Roles of activated Src and Stat3 signaling in melanoma tumor cell growth","volume":"21","author":"Niu","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2012.11.052_b0160","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1182\/blood-2002-07-2130","article-title":"Inhibition of STAT3 signaling induces apoptosis and decreases survivin expression in primary effusion lymphoma","volume":"101","author":"Aoki","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2012.11.052_b0165","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1038\/sj.onc.1205260","article-title":"Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis","volume":"21","author":"Niu","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2012.11.052_b0170","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1128\/MCB.18.5.2553","article-title":"Stat3 activation is required for cellular transformation by v-src","volume":"18","author":"Bromberg","year":"1998","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.canlet.2012.11.052_b0175","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1128\/MCB.18.5.2545","article-title":"Stat3 activation by Src induces specific gene regulation and is required for cell transformation","volume":"18","author":"Turkson","year":"1998","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.canlet.2012.11.052_b0180","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nrc1275","article-title":"The STATs of cancer-new molecular targets come of age","volume":"4","author":"Yu","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2012.11.052_b0185","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1038\/sj.onc.1203527","article-title":"STATs in oncogenesis","volume":"19","author":"Bowman","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2012.11.052_b0190","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1517\/14712598.6.3.231","article-title":"STAT3 as a therapeutic target in head and neck cancer","volume":"6","author":"Leeman","year":"2006","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.canlet.2012.11.052_b0195","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1172\/JCI3785","article-title":"Requirement of Stat3 but not Stat1 activation for epidermal growth factor receptor- mediated cell growth In vitro","volume":"102","author":"Grandis","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.canlet.2012.11.052_b0200","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1038\/sj.onc.1204349","article-title":"Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells","volume":"20","author":"Garcia","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2012.11.052_b0205","first-page":"1225","article-title":"Inhibition of constitutively activated Stat3 signaling pathway suppresses growth of prostate cancer cells","volume":"60","author":"Ni","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2012.11.052_b0210","first-page":"6659","article-title":"Constitutive activation of Stat3 in human prostate tumors and cell lines: direct inhibition of Stat3 signaling induces apoptosis of prostate cancer cells","volume":"62","author":"Mora","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2012.11.052_b0215","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1038\/sj.onc.1206479","article-title":"Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells","volume":"22","author":"Song","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2012.11.052_b0220","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ccr.2009.01.002","article-title":"Gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis","volume":"15","author":"Bollrath","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2012.11.052_b0225","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ccr.2008.12.018","article-title":"Regulation of the IL-23 and IL-12 balance by Stat3 signaling in the tumor microenvironment","volume":"15","author":"Kortylewski","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2012.11.052_b0230","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1084\/jem.20090207","article-title":"IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway","volume":"206","author":"Wang","year":"2009","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.canlet.2012.11.052_b0235","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ccr.2009.01.001","article-title":"IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer","volume":"15","author":"Grivennikov","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2012.11.052_b0240","doi-asserted-by":"crossref","first-page":"3846","DOI":"10.1172\/JCI31871","article-title":"Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas","volume":"117","author":"Gao","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.canlet.2012.11.052_b0245","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/ng.341","article-title":"A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasms","volume":"41","author":"Olcaydu","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.canlet.2012.11.052_b0250","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/nature07475","article-title":"Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours","volume":"457","author":"Rebouissou","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2012.11.052_b0255","first-page":"1727","article-title":"STAT3 and STAT1 mediate IL-11-dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice","volume":"118","author":"Ernst","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.canlet.2012.11.052_b0260","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1126\/science.8140422","article-title":"Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6","volume":"264","author":"Zhong","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.canlet.2012.11.052_b0265","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0092-8674(94)90235-6","article-title":"Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway","volume":"77","author":"Akira","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2012.11.052_b0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj20030407","article-title":"Principles of interleukin (IL)-6-type cytokine signalling and its regulation","volume":"374","author":"Heinrich","year":"2003","journal-title":"Biochem. J."},{"key":"10.1016\/j.canlet.2012.11.052_b0275","doi-asserted-by":"crossref","first-page":"8494","DOI":"10.1158\/0008-5472.CAN-07-0647","article-title":"Activation of the signal transducers and activators of the transcription 3 pathway in alveolar epithelial cells induces inflammation and adenocarcinomas in mouse lung","volume":"67","author":"Li","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2012.11.052_b0280","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1053\/j.gastro.2006.07.018","article-title":"STAT3 activation regulates growth, inflammation, and vascularization in a mouse model of gastric tumorigenesis","volume":"131","author":"Judd","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.canlet.2012.11.052_b0285","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1053\/j.gastro.2006.04.025","article-title":"Deletion of the SOCS3 gene in liver parenchymal cells promotes hepatitis-induced hepatocarcinogenesis","volume":"131","author":"Ogata","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.canlet.2012.11.052_b0290","doi-asserted-by":"crossref","first-page":"3397","DOI":"10.1038\/sj.onc.1208469","article-title":"Stat3 regulates genes common to both wound healing and cancer","volume":"24","author":"Dauer","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2012.11.052_b0295","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1158\/1535-7163.MCT-06-0561","article-title":"Deactivation of Akt and STAT3 signaling promotes apoptosis, inhibits proliferation, and enhances the sensitivity of hepatocellular carcinoma cells to an anticancer agent, Atiprimod","volume":"6","author":"Choudhari","year":"2007","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.canlet.2012.11.052_b0300","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1126\/science.7604283","article-title":"Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-I","volume":"269","author":"Migone","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.canlet.2012.11.052_b0305","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.bbrc.2008.11.053","article-title":"Epstein-Barr virus-derived EBNA2 regulates STAT3 activation","volume":"378","author":"Muromoto","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.canlet.2012.11.052_b0310","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nrc2734","article-title":"STATs in cancer inflammation and immunity: a leading role for STAT3","volume":"9","author":"Yu","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2012.11.052_b0315","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ccr.2009.02.015","article-title":"Persistently activated Stat3 maintains constitutive NF-kappaB activity in tumors","volume":"15","author":"Lee","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2012.11.052_b0320","first-page":"153","article-title":"Phosphorylation and nuclear translocation of STAT3 regulated by the Epstein-Barr virus latent membrane protein 1 in nasopharyngeal carcinoma","volume":"21","author":"Liu","year":"2008","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.canlet.2012.11.052_b0325","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1002\/hed.21611","article-title":"Immunohistochemical study identifying prognostic biomolecular markers in nasopharyngeal carcinoma treated by radiotherapy","volume":"33","author":"Kim","year":"2011","journal-title":"Head Neck"},{"key":"10.1016\/j.canlet.2012.11.052_b0330","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s00428-006-0294-2","article-title":"Expression of Epstein-Barr virus (EBV)-encoded latent membrane proteins and STAT3 activation in nasopharyngeal carcinoma","volume":"449","author":"Buettner","year":"2006","journal-title":"Virchows Arch."},{"key":"10.1016\/j.canlet.2012.11.052_b0335","doi-asserted-by":"crossref","first-page":"9066","DOI":"10.1158\/0008-5472.CAN-07-0575","article-title":"Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial\u2013mesenchymal transition in cancer cells via up-regulation of TWIST gene expression","volume":"67","author":"Lo","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2012.11.052_b0340","doi-asserted-by":"crossref","first-page":"14665","DOI":"10.1074\/jbc.M707429200","article-title":"Twist is transcriptionally induced by activation of STAT3 and mediates STAT3 oncogenic function","volume":"283","author":"Cheng","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2012.11.052_b0345","doi-asserted-by":"crossref","first-page":"3550","DOI":"10.1038\/sj.onc.1207383","article-title":"Stat3 activation regulates the expression of matrix metalloproteinase-2 and tumor invasion and metastasis","volume":"23","author":"Xie","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2012.11.052_b0350","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.1158\/0008-5472.CAN-05-2674","article-title":"Activation of stat3 in human melanoma promotes brain metastasis","volume":"66","author":"Xie","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2012.11.052_b0355","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1038\/sj.onc.1209149","article-title":"Requirement of STAT3 activation for maximal collagenase-1 (MMP-1) induction by epidermal growth factor and malignant characteristics in T24 bladder cancer cells","volume":"25","author":"Itoh","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2012.11.052_b0360","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1097\/00005537-200012000-00017","article-title":"The relationship between microvessel density, the expression of vascular endothelial growth factor (VEGF), and the extension of nasopharyngeal carcinoma","volume":"110","author":"Guang-Wu","year":"2000","journal-title":"Laryngoscope"},{"key":"10.1016\/j.canlet.2012.11.052_b0365","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1002\/ijc.23415","article-title":"Reactive nitrogen species-dependent DNA damage in EBV-associated nasopharyngeal carcinoma: the relation to STAT3 activation and EGFR expression","volume":"122","author":"Ma","year":"2008","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2012.11.052_b0370","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1073\/pnas.0237137100","article-title":"STAT3 deletion during hematopoiesis causes Crohn\u2019s disease-like pathogenesis and lethality: a critical role of STAT3 in innate immunity","volume":"100","author":"Welte","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.canlet.2012.11.052_b0375","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nm976","article-title":"Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells","volume":"10","author":"Wang","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2012.11.052_b0380","first-page":"OL1442","article-title":"Identification of G2607A mutation in EGFR gene with a significative rate in Moroccan patients with nasopharyngeal carcinoma","volume":"Suppl. 56","author":"Naji","year":"2010","journal-title":"Cell. Mol. Biol. (Noisy-le-grand)"},{"key":"10.1016\/j.canlet.2012.11.052_b0385","doi-asserted-by":"crossref","first-page":"13247","DOI":"10.1073\/pnas.1110486108","article-title":"Essential role of Stat3 in PI3K-induced oncogenic transformation","volume":"108","author":"Hart","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.canlet.2012.11.052_b0390","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s12032-008-9124-5","article-title":"PIK3CA mutation occurs in nasopharyngeal carcinoma but does not significantly influence the disease-specific survival","volume":"26","author":"Chou","year":"2009","journal-title":"Med. Oncol."},{"key":"10.1016\/j.canlet.2012.11.052_b0395","first-page":"467","article-title":"Genome wide detection of oncogene amplifications in nasopharyngeal carcinoma by array based comparative genomic hybridization","volume":"20","author":"Hui","year":"2002","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.canlet.2012.11.052_b0400","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s10637-009-9316-7","article-title":"Preclinical activity of gefitinib in non-keratinizing nasopharyngeal carcinoma cell lines and biomarkers of response","volume":"28","author":"Ma","year":"2010","journal-title":"Invest. New Drugs"},{"key":"10.1016\/j.canlet.2012.11.052_b0405","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1002\/hed.10307","article-title":"Prognostic significance of tumor angiogenesis, Ki 67, p53 oncoprotein, epidermal growth factor receptor and HER2 receptor protein expression in undifferentiated nasopharyngeal carcinoma \u2013 a prospective study","volume":"25","author":"Ma","year":"2003","journal-title":"Head Neck"},{"key":"10.1016\/j.canlet.2012.11.052_b0410","doi-asserted-by":"crossref","first-page":"4139","DOI":"10.1128\/JVI.77.7.4139-4148.2003","article-title":"A positive autoregulatory loop of LMP1 expression and STAT activation in epithelial cells latently infected with Epstein-Barr virus","volume":"77","author":"Chen","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.canlet.2012.11.052_b0415","doi-asserted-by":"crossref","first-page":"9150","DOI":"10.1073\/pnas.90.19.9150","article-title":"Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation","volume":"90","author":"Kaye","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.canlet.2012.11.052_b0420","doi-asserted-by":"crossref","first-page":"4399","DOI":"10.1128\/JVI.01703-10","article-title":"Epstein-Barr virus LMP1 activates EGFR, STAT3, and ERK through effects on PKCdelta","volume":"85","author":"Kung","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.canlet.2012.11.052_b0425","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1476-4598-10-11","article-title":"Lymphocyte deficiency limits Epstein-Barr virus latent membrane protein 1 induced chronic inflammation and carcinogenic pathology in vivo","volume":"10","author":"Hannigan","year":"2011","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2012.11.052_b0430","doi-asserted-by":"crossref","first-page":"5352","DOI":"10.1128\/JVI.07035-11","article-title":"Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) and LMP2A function cooperatively to promote carcinoma development in a mouse carcinogenesis model","volume":"86","author":"Shair","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.canlet.2012.11.052_b0435","first-page":"813","article-title":"The elevated serum interleukin-6 correlates with the increased serum butyrate level in patients with nasopharyngeal carcinoma","volume":"10","author":"Chow","year":"2003","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.canlet.2012.11.052_b0440","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1038\/sj.onc.1201258","article-title":"Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappaB pathway involving TNF receptor-associated factors","volume":"14","author":"Eliopoulos","year":"1997","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2012.11.052_b0445","doi-asserted-by":"crossref","first-page":"16085","DOI":"10.1074\/jbc.274.23.16085","article-title":"Activation of the p38 mitogen-activated protein kinase pathway by Epstein-Barr virus-encoded latent membrane protein 1 coregulates interleukin-6 and interleukin-8 production","volume":"274","author":"Eliopoulos","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2012.11.052_b0450","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/j.biocel.2005.04.012","article-title":"Epstein-Barr virus encoded latent membrane protein 1 modulates nuclear translocation of telomerase reverse transcriptase protein by activating nuclear factor-kappaB p65 in human nasopharyngeal carcinoma cells","volume":"37","author":"Ding","year":"2005","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.canlet.2012.11.052_b0455","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1038\/onc.2010.490","article-title":"Inhibition of c-Met downregulates TIGAR expression and reduces NADPH production leading to cell death","volume":"30","author":"Lui","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2012.11.052_b0460","doi-asserted-by":"crossref","first-page":"4390","DOI":"10.1128\/JVI.69.7.4390-4398.1995","article-title":"The Epstein-Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptor","volume":"69","author":"Miller","year":"1995","journal-title":"J. Virol."},{"key":"10.1016\/j.canlet.2012.11.052_b0465","doi-asserted-by":"crossref","first-page":"5486","DOI":"10.1128\/JVI.00125-08","article-title":"Epstein-Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptor through effects on Bcl-3 and STAT3","volume":"82","author":"Kung","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.canlet.2012.11.052_b0470","first-page":"589","article-title":"Met protein expression level correlates with survival in patients with late-stage nasopharyngeal carcinoma","volume":"62","author":"Qian","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2012.11.052_b0475","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/34657","article-title":"Induction of epithelial tubules by growth factor HGF depends on the STAT pathway","volume":"391","author":"Boccaccio","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2012.11.052_b0480","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/sj.onc.1205004","article-title":"Requirement of Stat3 signaling for HGF\/SF-Met mediated tumorigenesis","volume":"21","author":"Zhang","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2012.11.052_b0485","first-page":"1270","article-title":"Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase\/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice","volume":"63","author":"Blaskovich","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2012.11.052_b0490","first-page":"2948","article-title":"Epidermal growth factor receptor-independent constitutive activation of STAT3 in head and neck squamous cell carcinoma is mediated by the autocrine\/paracrine stimulation of the interleukin 6\/gp130 cytokine system","volume":"63","author":"Sriuranpong","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2012.11.052_b0495","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/379645a0","article-title":"Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor","volume":"379","author":"Meydan","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2012.11.052_b0500","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1038\/sj.leu.2404750","article-title":"TG101209, a small molecule JAK2-selective kinase inhibitor potently inhibits myeloproliferative disorder-associated JAK2V617F and MPLW515L\/K mutations","volume":"21","author":"Pardanani","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.canlet.2012.11.052_b0505","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1038\/sj.onc.1210031","article-title":"A novel inhibitor of the STAT3 pathway induces apoptosis in malignant glioma cells both in vitro and in vivo","volume":"26","author":"Iwamaru","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2012.11.052_b0510","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ccr.2009.10.015","article-title":"The JAK2 inhibitor AZD1480 potently blocks Stat3 signaling and oncogenesis in solid tumors","volume":"16","author":"Hedvat","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2012.11.052_b0515","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1593\/neo.91192","article-title":"INCB16562, a JAK1\/2 selective inhibitor, is efficacious against multiple myeloma cells and reverses the protective effects of cytokine and stromal cell support","volume":"12","author":"Li","year":"2010","journal-title":"Neoplasia"},{"key":"10.1016\/j.canlet.2012.11.052_b0520","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s11060-011-0786-z","article-title":"Induction of cell-cycle arrest and apoptosis in glioblastoma stem-like cells by WP1193, a novel small molecule inhibitor of the JAK2\/STAT3 pathway","volume":"107","author":"Sai","year":"2012","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.canlet.2012.11.052_b0525","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1038\/nm1010-1085","article-title":"Peering into the aftermath: JAKi rips STAT3 in cancer","volume":"16","author":"Greten","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2012.11.052_b0530","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1158\/0008-5472.CAN-09-2468","article-title":"Novel STAT3 phosphorylation inhibitors exhibit potent growth-suppressive activity in pancreatic and breast cancer cells","volume":"70","author":"Lin","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2012.11.052_b0535","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/1476-4598-9-217","article-title":"A novel small molecule inhibits STAT3 phosphorylation and DNA binding activity and exhibits potent growth suppressive activity in human cancer cells","volume":"9","author":"Lin","year":"2010","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2012.11.052_b0540","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/1476-4598-9-165","article-title":"The small molecule curcumin analog FLLL32 induces apoptosis in melanoma cells via STAT3 inhibition and retains the cellular response to cytokines with anti-tumor activity","volume":"9","author":"Bill","year":"2010","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2012.11.052_b0545","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1001\/archoto.2011.63","article-title":"Sensitization of head and neck cancer to cisplatin through the use of a novel curcumin analog","volume":"137","author":"Abuzeid","year":"2011","journal-title":"Arch. Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.canlet.2012.11.052_b0550","doi-asserted-by":"crossref","first-page":"45443","DOI":"10.1074\/jbc.M107527200","article-title":"Phosphotyrosyl peptides block Stat3-mediated DNA binding activity, gene regulation, and cell transformation","volume":"276","author":"Turkson","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2012.11.052_b0555","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1158\/1535-7163.261.3.3","article-title":"Novel peptidomimetic inhibitors of signal transducer and activator of transcription 3 dimerization and biological activity","volume":"3","author":"Turkson","year":"2004","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.canlet.2012.11.052_b0560","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1021\/jm801491w","article-title":"Conformationally constrained peptidomimetic inhibitors of signal transducer and activator of transcription. 3: Evaluation and molecular modeling","volume":"52","author":"Mandal","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.canlet.2012.11.052_b0565","doi-asserted-by":"crossref","first-page":"7391","DOI":"10.1073\/pnas.0609757104","article-title":"Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity","volume":"104","author":"Siddiquee","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.canlet.2012.11.052_b0570","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1002\/cmdc.200800123","article-title":"Molecular approaches towards the inhibition of the signal transducer and activator of transcription 3 (Stat3) protein","volume":"3","author":"Fletcher","year":"2008","journal-title":"ChemMedChem"},{"key":"10.1016\/j.canlet.2012.11.052_b0575","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/ncponc0195","article-title":"Mechanisms of disease: Insights into the emerging role of signal transducers and activators of transcription in cancer","volume":"2","author":"Haura","year":"2005","journal-title":"Nat. Clin. Pract. Oncol."},{"key":"10.1016\/j.canlet.2012.11.052_b0580","doi-asserted-by":"crossref","first-page":"4227","DOI":"10.1073\/pnas.97.8.4227","article-title":"Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo","volume":"97","author":"Grandis","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.canlet.2012.11.052_b0585","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1172\/JCI200421032","article-title":"Disruption of Stat3 reveals a critical role in both the initiation and the promotion stages of epithelial carcinogenesis","volume":"114","author":"Chan","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.canlet.2012.11.052_b0735","unstructured":"J. Grandis, STAT3 DECOY in Head and Neck Cancer: ClinicalTrials.gov. Identifier: NCT00696176, entitled."},{"key":"10.1016\/j.canlet.2012.11.052_b0595","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1089\/jir.2009.0003","article-title":"Down-regulation of GRIM-19 expression is associated with hyperactivation of STAT3-induced gene expression and tumor growth in human cervical cancers","volume":"29","author":"Zhou","year":"2009","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.canlet.2012.11.052_b0600","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s11010-009-0133-2","article-title":"Overexpression of STAT3 in HPV-mediated cervical cancer in a north Indian population","volume":"330","author":"Sobti","year":"2009","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.canlet.2012.11.052_b0605","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/sj.bjc.6601003","article-title":"Constitutive activation of STAT3 and STAT5 is present in the majority of nasopharyngeal carcinoma and correlates with better prognosis","volume":"89","author":"Hsiao","year":"2003","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2012.11.052_b0610","first-page":"1070","article-title":"Correlation of Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) to fascin and phosphorylated Stat3 in nasopharyngeal carcinoma","volume":"27","author":"Liu","year":"2008","journal-title":"Ai Zheng"},{"key":"10.1016\/j.canlet.2012.11.052_b0615","doi-asserted-by":"crossref","first-page":"4138","DOI":"10.1073\/pnas.0534764100","article-title":"Targeted inhibition of Stat3 with a decoy oligonucleotide abrogates head and neck cancer cell growth","volume":"100","author":"Leong","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.canlet.2012.11.052_b0620","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1158\/1535-7163.1183.3.10","article-title":"Novel single-stranded oligonucleotides that inhibit signal transducer and activator of transcription 3 induce apoptosis in vitro and in vivo in prostate cancer cell lines","volume":"3","author":"Barton","year":"2004","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.canlet.2012.11.052_b0625","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1196\/annals.1378.063","article-title":"Targeting signal-transducer-and-activator-of-transcription-3 for prevention and therapy of cancer: modern target but ancient solution","volume":"1091","author":"Aggarwal","year":"2006","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.canlet.2012.11.052_b0630","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.canlet.2007.12.009","article-title":"Growth inhibition of human hepatocellular carcinoma cells by blocking STAT3 activation with decoy-ODN","volume":"262","author":"Sun","year":"2008","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2012.11.052_b0635","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/sj.onc.1208316","article-title":"In vivo antitumor efficacy of STAT3 blockade using a transcription factor decoy approach: implications for cancer therapy","volume":"24","author":"Xi","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2012.11.052_b0640","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/1471-2407-7-149","article-title":"Therapeutic effects of STAT3 decoy oligodeoxynucleotide on human lung cancer in xenograft mice, BMC","volume":"7","author":"Zhang","year":"2007","journal-title":"BMC Cancer"},{"key":"10.1016\/j.canlet.2012.11.052_b0645","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1089\/104454903770946665","article-title":"Targeting Stat3 with G-quartet oligodeoxynucleotides in human cancer cells","volume":"22","author":"Jing","year":"2003","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.canlet.2012.11.052_b0650","doi-asserted-by":"crossref","first-page":"6603","DOI":"10.1158\/0008-5472.CAN-03-4041","article-title":"G-quartet oligonucleotides: a new class of signal transducer and activator of transcription 3 inhibitors that suppresses growth of prostate and breast tumors through induction of apoptosis","volume":"64","author":"Jing","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2012.11.052_b0655","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1158\/1535-7163.MCT-05-0302","article-title":"Targeting signal transducer and activator of transcription 3 with G-quartet oligonucleotides: a potential novel therapy for head and neck cancer","volume":"5","author":"Jing","year":"2006","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.canlet.2012.11.052_b0660","first-page":"129","article-title":"Inhibition of Stat3 activation and tumor growth suppression of non-small cell lung cancer by G-quartet oligonucleotides","volume":"31","author":"Weerasinghe","year":"2007","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.canlet.2012.11.052_b0665","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1471-2407-3-23","article-title":"Knockdown of STAT3 expression by RNAi induces apoptosis in astrocytoma cells","volume":"3","author":"Konnikova","year":"2003","journal-title":"BMC Cancer"},{"key":"10.1016\/j.canlet.2012.11.052_b0670","doi-asserted-by":"crossref","first-page":"6333","DOI":"10.1158\/1078-0432.CCR-05-0148","article-title":"Down-regulation of signal transducer and activator of transcription 3 expression using vector-based small interfering RNAs suppresses growth of human prostate tumor in vivo","volume":"11","author":"Gao","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2012.11.052_b0675","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1158\/0008-5472.CAN-04-2425","article-title":"Knockdown of STAT3 expression by RNA interference inhibits the induction of breast tumors in immunocompetent mice","volume":"65","author":"Ling","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2012.11.052_b0680","doi-asserted-by":"crossref","first-page":"4700","DOI":"10.1073\/pnas.0409894102","article-title":"A low-molecular-weight compound discovered through virtual database screening inhibits Stat3 function in breast cancer cells","volume":"102","author":"Song","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.canlet.2012.11.052_b0685","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/1471-2407-7-111","article-title":"Signal transducer and activator of transcription 3 is involved in cell growth and survival of human rhabdomyosarcoma and osteosarcoma cells","volume":"7","author":"Chen","year":"2007","journal-title":"BMC Cancer"},{"key":"10.1016\/j.canlet.2012.11.052_b0690","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.bmcl.2007.10.031","article-title":"Design, synthesis, and studies of small molecule STAT3 inhibitors","volume":"18","author":"Bhasin","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.canlet.2012.11.052_b0695","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.chembiol.2006.09.018","article-title":"Stattic: a small-molecule inhibitor of STAT3 activation and dimerization","volume":"13","author":"Schust","year":"2006","journal-title":"Chem. Biol."},{"key":"10.1016\/j.canlet.2012.11.052_b0700","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1038\/sj.jid.5701246","article-title":"Cucurbitacin I inhibits Stat3 and induces apoptosis in sezary cells","volume":"128","author":"van Kester","year":"2008","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.canlet.2012.11.052_b0705","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1365-2141.2006.06259.x","article-title":"JSI-124 (cucurbitacin I) inhibits Janus kinase-3\/signal transducer and activator of transcription-3 signalling, downregulates nucleophosmin-anaplastic lymphoma kinase (ALK), and induces apoptosis in ALK-positive anaplastic large cell lymphoma cells","volume":"135","author":"Shi","year":"2006","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.canlet.2012.11.052_b0710","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.4161\/cbt.7.8.6263","article-title":"JSI-124 inhibits glioblastoma multiforme cell proliferation through G(2)\/M cell cycle arrest and apoptosis augment","volume":"7","author":"Su","year":"2008","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.canlet.2012.11.052_b0715","doi-asserted-by":"crossref","first-page":"37610","DOI":"10.1074\/jbc.M301629200","article-title":"Sequence-specific peptide aptamers, interacting with the intracellular domain of the epidermal growth factor receptor, interfere with Stat3 activation and inhibit the growth of tumor cells","volume":"278","author":"Buerger","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2012.11.052_b0720","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1158\/1541-7786.170.2.3","article-title":"The interaction of specific peptide aptamers with the DNA binding domain and the dimerization domain of the transcription factor Stat3 inhibits transactivation and induces apoptosis in tumor cells","volume":"2","author":"Nagel-Wolfrum","year":"2004","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.canlet.2012.11.052_b0725","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1158\/1541-7786.MCR-07-0245","article-title":"Monomeric recombinant peptide aptamers are required for efficient intracellular uptake and target inhibition","volume":"6","author":"Borghouts","year":"2008","journal-title":"Mol. Cancer Res."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383512007148?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383512007148?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T11:35:35Z","timestamp":1687865735000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383512007148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":145,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0304383512007148"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2012.11.052","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"STAT3 as a therapeutic target for Epstein-Barr virus (EBV) \u2013 associated nasopharyngeal carcinoma","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2012.11.052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Ireland Ltd. Published by Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}